The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis

Atherosclerosis

Volumn 225, Issue 1, 2012, Pages 173-179

  Lin, Cheng Jui ^a,b,c   Pan, Chi Feng ^a,b   Liu, Hsuan Liang ^c   Chuang, Chih Kuang ^a,c,d   Jayakumar, Thanasekaran ^c   Wang, Tuen Jen ^a   Chen, Han Hsiang ^a,b   Wu, Chih Jen ^a,b,e  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hemodialysis; Indoxyl sulfate; P Cresyl sulfate; Peripheral artery disease; Vascular access failure

Indexed keywords

4 CRESYL SULFATE; CHOLESTEROL; INDICAN; SERUM ALBUMIN; SULFATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREMIC TOXIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FOLLOW UP; HAZARD RATIO; HEMODIALYSIS; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PULSE WAVE; SCREENING; THROMBECTOMY; TREATMENT FAILURE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ACCESS;

ADULT; AGED; ANKLE BRACHIAL INDEX; CRESOLS; EQUIPMENT FAILURE; FEMALE; HUMANS; INDICAN; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PULSE WAVE ANALYSIS; RENAL DIALYSIS; TOXINS, BIOLOGICAL; VASCULAR ACCESS DEVICES;

EID: 84867885226     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.07.012     Document Type: Article

References (34)

1. Levin A., Foley R.N. Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 2000, 36:S24-S30.
2. Sarnak M.J., Coronado B.E., Greene T., et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 2002, 57:327-335.
3. Meijers B.K.I., Bammens B., De Moor B., et al. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 2008, 73:1173-1180.
4. Barreto F.C., Barreto D.V., Liabeuf S., et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009, 4:1551-1558.
5. Vanholder R., Massy Z., Argiles A., et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005, 20:1048-1056.
6. Bammens B., Evenepoel P., Keuleers H., et al. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006, 69:1081-1087.
7. Lin C.J., Wu C.J., Pan C.F., et al. Serum protein-bound uremic toxins and clinical outcomes in hemodialysis patients. Nephrol Dial Transplant 2010, 25:3693-3700.
8. Schepers E., Meert N., Glorieux G., et al. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 2007, 22:592-596.
9. Rayner H.C., Pisoni R.L., Bommer J., et al. Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2004, 19:108-120.
10. Weiss M.F., Scivittaro V., Anderson J.M. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 2001, 37:970-980.
11. Newman A.B., Tyrrell K.S., Kuller L.H. Mortality over four years in SHEP participants with a low ankle-arm index. J Am Geriatr Soc 1997, 45:1472-1478.
12. Ono K., Tsuchida A., Kawai H., et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 2003, 14:1591-1598.
13. Kitahara T., Ono K., Tsuchida A., et al. Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients. Am J Kidney Dis 2005, 46:688-696.
14. Weber T., Auer J., O'Rourke M.F., et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004, 109:184-189.
15. Hansen T.W., Staessen J.A., Torp-Pedersen C., et al. Ambulatory arterial stiffness index predicts stroke in a general population. J Hypertens 2006, 24:2247-2253.
16. Meijers B.K., Loor H.D., Bammens B., et al. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol 2009, 4:1932-1938.
17. Daugirdas J.T. The post:pre-dialysis plasma urea nitrogen ratio to estimate Kt/V and nPCR: mathematical modeling. Int J Artif Organs 1989, 12:411-419.
18. Rajagopalan S., Dellegrottaglie S., Furniss A.L., et al. Peripheral arterial disease in patients with end-stage renal disease, observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation 2006, 114:1914-1922.
19. Gibson K.D., Caps M.T., Kohler T.R., et al. Assessment of a policy to reduce placement of prosthetic hemodialysis access. Kidney Int 2001, 59:2335.
20. Chen S.C., Chang J.M., Hwang S.J., et al. Significant correlation between ankle-brachial index and vascular access failure in hemodialysis patients. Clin J Am Soc Nephrol 2009, 4:128-134.
21. Hofstra L., Tordoir J.H., Kitslaar P.J., et al. Enhanced cellular proliferation in intact stenotic lesions derived from human arteriovenous fistulas and peripheral bypass grafts. Does it correlate with flow parameters?. Circulation 1996, 94:1283-1290.
22. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
23. Lin C.J., Chen H.H., Pan C.F., et al. p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. J Clin Lab Anal 2011, 25:191-197.
24. Krieter D.H., Hackl A., Rodriguez A., et al. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 2010, 25:212-218.
25. Dou L., Bertrand E., Cerini C., et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004, 65:442-451.
26. Yamamoto H., Tsuruoka S., Ioka T., et al. Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int 2006, 69:1780-1785.
27. Mehler P.S., Coll J.R., Estacio R., et al. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 2003, 107:753-756.
28. Ichihara A., Hayashi M., Ryuzaki M., et al. Fluvastatin prevents development of arterial stiffness in hemodialysis patients with type 2 diabetes mellitus. Nephrol Dial Transplant 2002, 17:1513-1517.
29. Sigrist M.K., Taal M.W., Bungay P., et al. Progressive vascular calcification aver 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007, 2:1241-1248.
30. Toussaint N.D., Lau K.K., Strauss B.J., et al. Association between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 2008, 23:586-593.
31. Ichihara A., Hayashi M., Kaneshiro Y., et al. Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. Am J Kidney Dis 2005, 45:866-874.
32. Liabeuf S., Barreto D.V., Barreto F.C., et al. Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. Nephrol Dial Transplant 2009, 13:1-8.
33. Cofan F., Vela E., Clèries M. Collaborative Study Group for dyslipidemia. Analysis of dyslipidemia in patients on chronic hemodialysis in Catalonia. Atherosclerosis 2006, 184:94-102.
34. Puskar D., Pasini J., Savic I., et al. Survival of primary arteriovenous fistula in 463 patients on chronic hemodialysis. Croat Med J 2002, 43:306-311.